Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4070859
Max Phase: Preclinical
Molecular Formula: C56H88Cl4N12O3
Molecular Weight: 973.37
Molecule Type: Small molecule
Associated Items:
ID: ALA4070859
Max Phase: Preclinical
Molecular Formula: C56H88Cl4N12O3
Molecular Weight: 973.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCOc1c2cc(NC(=N)N)cc1Cc1cc(NC(=N)N)cc(c1OCCCCCCCC)Cc1cc(NC(=N)N)cc(c1OCCCCCCCC)Cc1cc(cc(NC(=N)N)c1)C2.Cl.Cl.Cl.Cl
Standard InChI: InChI=1S/C56H84N12O3.4ClH/c1-4-7-10-13-16-19-22-69-50-40-26-38-25-39(29-46(28-38)65-53(57)58)27-41-33-48(67-55(61)62)35-43(51(41)70-23-20-17-14-11-8-5-2)31-45-37-49(68-56(63)64)36-44(30-42(50)34-47(32-40)66-54(59)60)52(45)71-24-21-18-15-12-9-6-3;;;;/h25,28-29,32-37H,4-24,26-27,30-31H2,1-3H3,(H4,57,58,65)(H4,59,60,66)(H4,61,62,67)(H4,63,64,68);4*1H
Standard InChI Key: GSVSLNMXNPUVQV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 973.37 | Molecular Weight (Monoisotopic): 972.6789 | AlogP: 11.80 | #Rotatable Bonds: 28 |
Polar Surface Area: 275.29 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: | CX Basic pKa: 5.59 | CX LogP: 13.10 | CX LogD: 13.09 |
Aromatic Rings: 4 | Heavy Atoms: 71 | QED Weighted: 0.01 | Np Likeness Score: 0.14 |
1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F.. (2017) Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling., 60 (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095] |
Source(1):